Zydus Lifesciences Limited FII & DII Activity

Today's Institutional Flow

Today's cash flows show a stark contrast between foreign and domestic investors, with FIIs recording a net outflow of ₹‑3,111.94 Cr while DIIs posted a net inflow of ₹ 8,930.12 Cr amid heightened market volatility. The cumulative effect leaves the market with a net positive cash injection of roughly ₹ 5,818.18 Cr driven primarily by domestic participation and underscores the resilience of local capital. Such divergent behavior underscores the ongoing shift in capital allocation toward Indian equities as foreign sentiment remains cautious and may influence short‑term price dynamics.

Trend vs 5-Day Average

Compared with the five‑day averages, today's FII cash outflow of ₹‑3,111.94 Cr is slightly less aggressive than the average weekly net outflow of ₹‑3,333.81 Cr, reflecting a modest retreat. Conversely, DII buying of ₹ 8,930.12 Cr exceeds the five‑day average inflow of ₹ 4,430.43 Cr, indicating heightened domestic enthusiasm and supports a bullish outlook for the sector.

F&O Positioning Data

FIIs maintain a substantial long‑term futures and options (F&O) exposure of ₹ 374,795 Cr, reflecting continued hedge and speculative activity in the derivatives market amid ongoing regulatory scrutiny. Their index futures positioning remains mildly bullish, with a long‑to‑short ratio of 1.2, suggesting a tempered optimism among foreign traders.

Healthcare Sector Flow

Within the healthcare segment, FIIs have been net sellers over the past week while DIIs have consistently accumulated positions, reinforcing a domestic bias in the sector as domestic funds seek stable growth and underpin future earnings as the industry overall.